Corbus Pharmaceuticals Holdings, Inc. CRBP
Corbus Pharmaceuticals Holdings, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -6350.1% | -3119.2% | -213.3% | -1176.8% | -1334.4% | -1045.6% |
| Net margin | — | — | — | — | -5176.4% | -2826.1% | -197.7% | -1154.5% | -1328.6% | -1046.3% |
| FCF margin | — | — | — | — | -5471.0% | -2544.2% | -134.1% | -671.2% | -1168.1% | -728.5% |
| Return on assets | -46.7% | -25.8% | -157.8% | -63.9% | -42.4% | -108.8% | -145.4% | -118.5% | -48.4% | -111.8% |
| Return on equity | -53.2% | -28.2% | 646.0% | -128.4% | -66.0% | -245.8% | -1160.4% | -202.3% | -56.1% | -224.2% |
| Debt / equity | — | — | -2.59× | 0.65× | 0.31× | 0.47× | — | — | — | — |
| Current ratio | 8.07 | 12.94 | 0.74 | 4.76 | 5.89 | 2.89 | 1.09 | 2.45 | 7.98 | 1.96 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.